Overview

bortezomib


More Like This

Show all results sharing this subject:

  • Clinical Pharmacology and Therapeutics

GO

Show Summary Details

Quick Reference

(bor-tez-ŏ-mib)

a cytotoxic drug that is administered intravenously in the treatment of myeloma. Side-effects include peripheral neuropathy, thrombocytopenia, and nausea. Trade name:. Velcade.

Subjects: Clinical Pharmacology and Therapeutics.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.